Stryker Corp STRYKER ORD SHS
Stryker Corp STRYKER ORD SHS/ US8636671013 /
0R2S
|
15.11.2024 19:56:17
|
Zm.
-0,58
|
Wolumen |
Bid- |
Ask- |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
389,68USD
|
-0,15%
|
1 306
Obrót: 506 800,96 |
-Wolumen Bid: - |
-Wolumen Ask: - |
148,44 mldUSD |
0,78% |
46,69 |
Opis działalności
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Zarząd & Rada nadzorcza
| CEO |
| Kevin A. Lobo |
| Zarząd |
| Glenn Boehnlein, Yin Becker, Katy Fink, Rob Fletcher, Viju Menon, Andy Pierce, Spencer Stiles |
| Rada nadzorcza |
| Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Srikant M. Datar, Giovanni Caforio, Lisa M. Skeete Tatum, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy |
Dane firmy
| Nazwa: |
Stryker Corporation |
| Adres: |
2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA |
| Telefon: |
+1-269-385-2600 |
| Fax: |
+1-269-385-1062 |
| E-mail: |
-
|
| Internet: |
www.stryker.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
64,10% |
| Data IPO: |
01.01.1979 |
Główni akcjonariusze
| Inne |
|
62,26% |
| Vanguard Group Inc |
|
8,17% |
| BlackRock Inc. |
|
6,54% |
| Greenleaf Trust |
|
4,85% |
| State Street Corporation |
|
3,74% |
| Price T Rowe Associates Inc Md |
|
3,29% |
| Wellington Management Group |
|
3,19% |
| Capital Research Global Investor |
|
2,67% |
| JP Morgan Chase & Co. |
|
2,05% |
| Inne |
|
3,24% |
